Amylyx CMO Patrick Yeramian moves to part-time, salary reduced to $214K; successor search ongoing

Amylyx Pharmaceuticals, Inc.

CMO Patrick Yeramian's working hours reduced to 20 per week as of Dec 1, 2022.
Base salary adjusted to $214,000 annually from prior rate (not disclosed).
Company expects Yeramian to transition into retirement; no definitive date set.
Full-time successor search initiated as part of management succession process.
Yeramian's reduced schedule not the result of any disagreement with the company.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.